Feb 14 (Reuters) - Myokardia Inc:
* MYOKARDIA BEGINS PATIENT DOSING IN PHASE 1B CLINICAL STUDY OF MYK-491 IN DILATED CARDIOMYOPATHY PATIENTS
* MYOKARDIA INC - TOPLINE RESULTS FROM PHASE 1B STUDY OF MYK-491 ARE ANTICIPATED IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage: